Revised FIGO staging system for endometrial cancer

Clinical Obstetrics and Gynecology

Volumn 54, Issue 2, 2011, Pages 215-218

  Lewin, Sharyn N ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Endometrial cancer; FIGO; lymphadenectomy; staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; UTERINE CERVIX CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS;

EID: 79955550125     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182185baa     Document Type: Article

References (20)

1. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.
2. Morrow CP, Bundy BN, Kurman RJ, et al.Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.
3. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984; 63:825-832. (Pubitemid 14105231)
4. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer. 1987; 60:2035-2041. (Pubitemid 17145924)
5. Lewin SN, Herzog TH, Medel NI, et al. Comparative performance of the 2009 Internationl Federation of gynecology and obstetrics' staging systemfor uterine corpus cancer. Obstet Gyn. 2010;116:1141-1149.
6. Chan JK, Wu H, Cheung MK, et al. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007;106:282-288. (Pubitemid 47096660)
7. Straughn JM Jr, Huh WK, Kelly FJ, et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol. 2002;84:194-200. (Pubitemid 34136768)
8. Reisinger SA, Staros EB, Mohiuddin M. Survival and failure analysis in stage II endometrial cancer using the revised 1988 FIGO staging system. Int J Radiat Oncol Biol Phys. 1991;21:1027-1032.
9. Sartori E, Gadducci A, Landoni F, et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer. 2001;11:430-437. (Pubitemid 34024800)
10. DiSaia PJ, Creasman WT, Boronow RC, et al. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009-1015. (Pubitemid 15039768)
11. GrevenKM,Lanciano RM,Corn B, et al. Pathologic stage III endometrial carcinoma: prognostic factors and patterns of recurrence. Cancer. 1993;71:3697-3702. (Pubitemid 23152686)
12. GellerMA, Ivy J, Dusenbery KE, et al. A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma. Gynecol Oncol. 2010;118:19-23.
13. Secord AA, Havrilesky LJ, O'Malley DM, et al. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Gynecol Oncol. 2009;114:442-447.
14. Bansal S, Buck AM, Herzog TJ, et al. Stage IIIA endometrial carcinoma: outcome and predictors of survival. Obstet Gynecol. 2009;114:100-105.
15. Havrilesky LJ, Cragun JM, Calingaert B, et al. The prognostic significance of positive peritoneal cytology and adnexal/ serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007;104: 401-405. (Pubitemid 46135654)
16. Mariani A, Webb MJ, Keeney GL, et al. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002;86:38-44. (Pubitemid 34757049)
17. Mariani A, Dowdy SC, PodratzKC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet. 2009; 105:110-111.
18. Seamon LG, Fowler JM, CohnDE. Lymphadenectomy for endometrial cancer: the controversy.Gynecol Oncol. 2010;117:6-8.
19. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy versus no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707-1716.
20. Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125-136.